Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke (SAPPHIRE)

July 8, 2009 updated by: AstraZeneca

A Retrospective, Multi Centre, Non-Interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Post Stroke Patients With Hypertension.

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors that affect BP control by examining retrospective medical records of hypertension patients recovering from stroke, among outpatients coming to the Neurology Department in 10 university hospitals nationwide.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
      • Busan, Korea, Republic of
        • Research Site
      • Deagu, Korea, Republic of
        • Research Site
      • Deajeon, Korea, Republic of
        • Research Site
      • Kwangju, Korea, Republic of
        • Research Site
      • Seoul, Korea, Republic of
        • Research Site
    • Gyeonggi
      • Goyang, Gyeonggi, Korea, Republic of
        • Research Site
      • Sungnam, Gyeonggi, Korea, Republic of
        • Research Site
    • Kangwon
      • Wonju, Kangwon, Korea, Republic of
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient with history of stroke, receiving hypertension medication during at least 1 year.

Description

Inclusion Criteria:

  • Patients had been hospitalized as a acute stroke in 2006
  • Patient with history of stroke receiving hypertension medication during at least 1 year.

Exclusion Criteria:

  • Secondary hypertension patients
  • Patients not receiving hypertension medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
1
Hypertension patients recovering from stroke

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Attainment rate to the target blood pressure
Time Frame: After collecting all Patient Record Form.
After collecting all Patient Record Form.

Secondary Outcome Measures

Outcome Measure
Time Frame
Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases.
Time Frame: After collecting all Patient Record Form.
After collecting all Patient Record Form.
Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease.
Time Frame: After collecting all Patient Record Form.
After collecting all Patient Record Form.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Study Director: Joon Woo Bahn, Astrazenca Korea medical dept.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2008

Study Completion (Actual)

July 1, 2008

Study Registration Dates

First Submitted

May 19, 2008

First Submitted That Met QC Criteria

May 20, 2008

First Posted (Estimate)

May 21, 2008

Study Record Updates

Last Update Posted (Estimate)

July 9, 2009

Last Update Submitted That Met QC Criteria

July 8, 2009

Last Verified

July 1, 2009

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-CKR-DUM-2008/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe